Raphas Co., Ltd. Logo

Raphas Co., Ltd.

Develops dissolving microneedle patches for cosmetic, medical, and pharmaceutical applications.

214260 | KO

Overview

Corporate Details

ISIN(s):
KR7214260002
LEI:
Country:
South Korea
Address:
서울특별시 강서구 마곡중앙8로1길 62 라파스, 강서구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Raphas Co., Ltd. is a biotechnology company specializing in the research, development, and manufacturing of its proprietary transdermal delivery platform. The company's core technology is the patented Dissolving Microneedle (DEN), which enables the effective delivery of active ingredients for cosmetic, medical device, and pharmaceutical applications. Raphas develops and mass-produces innovative microarray patches, commercializing its technology through its own cosmetics brand, Acropass, as well as through partnerships. The platform offers solutions for skin care, including wrinkle and whitening treatments, and is being developed for the potential delivery of drugs and vaccines.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 2.0 MB
2025-08-14 00:00
Interim / Quarterly Report
[기재정정]반기보고서 (2025.06)
Korean 2.0 MB
2025-07-28 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 11.9 KB
2025-06-09 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-06-09 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 127.7 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 2.0 MB
2025-04-28 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 11.5 KB
2025-03-26 00:00
AGM Information
정기주주총회결과
Korean 21.1 KB
2025-03-18 00:00
Audit Report / Information
감사보고서제출
Korean 25.8 KB
2025-03-18 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 373.5 KB
2025-03-18 00:00
Proxy Solicitation & Information Statement
[기재정정]의결권대리행사권유참고서류
Korean 361.8 KB
2025-03-18 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 723.2 KB
2025-03-05 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
Korean 11.9 KB
2025-03-05 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 15.6 KB
2025-03-05 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 189.7 KB

Automate Your Workflow. Get a real-time feed of all Raphas Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Raphas Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Raphas Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Entera Bio Ltd. Logo
Developing oral versions of injectable drugs for osteoporosis, hypoparathyroidism, and obesity.
United States of America
ENTX
Entero Therapeutics, Inc. Logo
Develops targeted oral therapies for a range of gastrointestinal (GI) diseases.
United States of America
ENTO
Entrada Therapeutics, Inc. Logo
Developing intracellular therapeutics for rare neuromuscular diseases via its EEV™ platform.
United States of America
TRDA
Develops novel therapeutics and APIs for oncology, inflammation, and respiratory diseases.
South Korea
183490
Enzymatica AB Logo
Develops medical devices with patented enzyme technology to treat upper respiratory infections.
Sweden
ENZY
Epitomee Medical Ltd. Logo
Develops ingestible therapeutic devices for weight management and targeted drug delivery.
Israel
EPIT
EQL Pharma AB Logo
Develops and sells cost-efficient niche generic medicines for the Nordic healthcare market.
Sweden
EQL
Erasca, Inc. Logo
Clinical-stage oncology company developing therapies targeting the RAS/MAPK pathway in cancer.
United States of America
ERAS
Ernexa Therapeutics Inc. Logo
Developing targeted, off-the-shelf cell therapies for cancer and autoimmune diseases.
United States of America
ERNA
ERYTECH Pharma S.A. Logo
Developing phage therapies to combat antibiotic-resistant bacterial infections.
France
ERYP

Talk to a Data Expert

Have a question? We'll get back to you promptly.